Bernardo A., Ajmone-Cat M. A., Levi G. and Minghetti L. (2003)
15-deoxy-D12,14-prostaglandin J2 regulates the functional state and
the survival of microglial cells through multiple molecular mechanisms. J. Neurochem. 87, 742–751.
Bohuslav J., Kravchenko V. V., Parry G. C., Erlich J. H., Gerondakis S.,
Mackman N. and Ulevitch R. J. (1998) Regulation of an essential
innate immune response by the p50 subunit of NF-kappaB. J. Clin.
Invest. 102, 1645–1652.
Boje K. M., Jaworowicz D. Jr and Raybon J. J. (2003) Neuroinflammatory role of prostaglandins during experimental meningitis:
evidence suggestive of an in vivo relationship between nitric oxide
and prostaglandins. J. Pharmacol. Exp. Ther. 304, 319–325.
Brock T. G., McNish R. W. and Peters-Golden M. (1999) Arachidonic
acid is preferentially metabolized by cyclooxygenase-2 to prostacyclin and prostaglandin E2. J. Biol. Chem. 274, 11660–11666.
Colasanti M., Persichini T., Menegazzi M., Mariotto S., Giordano E.,
Caldarera C. M., Sogos V., Lauro G. M. and Suzuki H. (1995)
Induction of nitric oxide synthase mRNA expression. Suppression
by exogenous nitric oxide. J. Biol. Chem. 270, 26731–26733.
Ek M., Engblom D., Saha S., Blomqvist A., Jakobsson P. J. and Ericsson-Dahlstrand A. (2001) Inflammatory response: pathway across
the blood–brain barrier. Nature 410, 430–431.
Eliopoulos A. G., Dumitru C. D., Wang C. C., Cho J. and Tsichlis P. N.
(2002) Induction of COX-2 by LPS in macrophages is regulated by
Tpl2-dependent CREB activation signals. EMBO J. 21, 4831–
4840.
Fabrizi C., Silei V., Menegazzi M., Salmona M., Bugiani O., Tagliavini
F., Suzuki H. and Lauro G. M. (2001) The stimulation of inducible
nitric-oxide synthase by the prion protein fragment 106–126 in
human microglia is tumor necrosis factor-alpha-dependent and
involves p38 mitogen-activated protein kinase. J. Biol. Chem. 276,
25692–25696.
Ferlito M., Romanenko O. G., Ashton S., Squadrito F., Halushka P. V.
and Cook J. A. (2001) Effect of cross-tolerance between endotoxin
and TNF-alpha or IL-1beta on cellular signaling and mediator
production. J. Leukoc. Biol. 70, 821–829.
Greco A., Ajmone-Cat M. A., Nicolini A., Sciulli M. G. and Minghetti
L. (2003) Paracetamol effectively reduces prostaglandin E2 synthesis in brain macrophages by inhibiting enzymatic activity of
cyclooxygenase but not phospholipase and prostaglandin E synthase. J. Neurosci. Res. 71, 844–852.
Harris S. G., Padilla J., Koumas L., Ray D. and Phipps R. P. (2002)
Prostaglandins as modulators of immunity. Trends Immunol. 23,
144–150.
Kim K. S. (2003) Pathogenesis of bacterial meningitis: from bacteraemia to neuronal injury. Nat. Rev. Neurosci. 4, 376–385.
Kim E. J., Kwon K. J., Park J. Y., Lee S. H., Moon C. H. and Baik E. J.
(2002) Neuroprotective effects of prostaglandin E2 or cAMP
against microglial and neuronal free radical mediated toxicity
associated with inflammation. J. Neurosci. Res. 70, 97–107.
Kinjyo I., Hanada T., Inagaki-Ohara K., Mori H., Aki D., Ohishi M.,
Yoshida H., Kubo M. and Yoshimura A. (2002) SOCS1/JAB is a
negative regulator of LPS-induced macrophage activation. Immunity 17, 583–591.
Kobayashi K., Hernandez L. D., Galan J. E., Janeway C. A. Jr, Medzhitov R. and Flavell R. A. (2002) IRAK-M is a negative
regulator of Toll-like receptor signaling. Cell 110, 191–202.
Koistinaho M. and Koistinaho J. (2002) Role of p38 and p44/42 mitogen-activated protein kinases in microglia. Glia 40, 175–183.
Kreutzberg G. W. (1996) Microglia: a sensor for pathological events in
the CNS. Trends Neurosci. 19, 312–318.
Landreth G. and Heneka M. T. (2001) Anti-inflammatory actions of
peroxisome proliferator-activated receptor gamma agonists in
Alzheimer's disease. Neurobiol. Aging 22, 937–944.
